Millennium co-founder ventures into epigenetics-based drugs

04/29/2008 | Boston Globe (tiered subscription model), The

Mark Levin, co-founder and board member of Millennium Pharmaceuticals, hopes to replicate the success of the Cambridge, Mass.-based biotech firm at his new venture, Constellation Pharmaceuticals. The startup company aims to develop cancer drugs through epigenetics -- the study of how to switch genes on and off without affecting the underlying DNA sequence.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA